FDA MedWatch - Aerosol Dry Conditioner Spray Products and Aerosol Dry Shampoo Spray Products by P&G:

Recall - Due to the Presence of Benzene Detected in Some Products

If your email program has trouble displaying this email, view as a webpage. MedWatch - The FDA Safety Information and Adverse Event Reporting Program TOPIC: Aerosol Dry Conditioner Spray Products and Aerosol Dry Shampoo Spray Products by P&G: Recall - Due to the Presence of Benzene Detected in Some Products AUDIENCE: Consumer, Health Professional, Pharmacy ISSUE: Procter & Gamble (P&G) is recalling aerosol dry conditioner spray products and aerosol dry shampoo spray products from Pantene, Aussie, Herbal Essences, and Waterless in addition to previously discontinued aerosol dry shampoo products from Old Spice and Hair Food, due to the presence of benzene detected in some products. Risk Statement: Benzene is classified as a human carcinogen. Exposure to benzene can occur by inhalation, orally, and through the skin and it can result in cancers including leukemia and blood cancer of the bone marrow and blood disorders which can be life-threatening. Based on exposure modeling and the cancer risk assessments published by the Environmental Protection Agency (EPA) (IRIS database), daily exposure to benzene in the recalled products at the levels detected in our testing would not be expected to cause adverse health consequences.  To date, Procter & Gamble has not received any reports of adverse events related to this recall and is conducting this recall out of an abundance of caution. For more information about this recall, click on the red button "Read Recall" below. BACKGROUND: The affected products are used as hygiene products and are packaged in aerosol cans. RECOMMENDATIONS: Consumers should stop using and appropriately discard the affected aerosol dry conditioner spray products and aerosol dry shampoo spray products. Consumers and health professionals are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program: Complete and submit the report online. Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA